Titre : Lésions malpighiennes intra-épithéliales du col utérin

Lésions malpighiennes intra-épithéliales du col utérin : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lésions malpighiennes intra-épithéliales du col utérin : Questions médicales les plus fréquentes", "headline": "Lésions malpighiennes intra-épithéliales du col utérin : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lésions malpighiennes intra-épithéliales du col utérin : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-28", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lésions malpighiennes intra-épithéliales du col utérin" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lésions malpighiennes intra-épithéliales", "url": "https://questionsmedicales.fr/mesh/D000081483", "about": { "@type": "MedicalCondition", "name": "Lésions malpighiennes intra-épithéliales", "code": { "@type": "MedicalCode", "code": "D000081483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.149.688" } } }, "about": { "@type": "MedicalCondition", "name": "Lésions malpighiennes intra-épithéliales du col utérin", "alternateName": "Squamous Intraepithelial Lesions of the Cervix", "code": { "@type": "MedicalCode", "code": "D065310", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hyun-Soo Kim", "url": "https://questionsmedicales.fr/author/Hyun-Soo%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea." } }, { "@type": "Person", "name": "Lihui Wei", "url": "https://questionsmedicales.fr/author/Lihui%20Wei", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, P.R. China." } }, { "@type": "Person", "name": "Zhongqiu Lin", "url": "https://questionsmedicales.fr/author/Zhongqiu%20Lin", "affiliation": { "@type": "Organization", "name": "Department of Gynecological Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, PR China." } }, { "@type": "Person", "name": "Rita Maira Zanine", "url": "https://questionsmedicales.fr/author/Rita%20Maira%20Zanine", "affiliation": { "@type": "Organization", "name": "Department of Gynecology and Obstetrics, Lower Genital Tract Disease and Colposcopy Sector, Clinics Hospital of the University of Paraná, Curitiba, PR, Brazil." } }, { "@type": "Person", "name": "Hyunjin Kim", "url": "https://questionsmedicales.fr/author/Hyunjin%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Personalized approach to management of high-grade squamous intraepithelial lesion.", "datePublished": "2022-07-29", "url": "https://questionsmedicales.fr/article/35908683", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.pdpdt.2022.103038" } }, { "@type": "ScholarlyArticle", "name": "Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum.", "datePublished": "2024-03-29", "url": "https://questionsmedicales.fr/article/38547493", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/AOG.0000000000005566" } }, { "@type": "ScholarlyArticle", "name": "Association Between Recurrence of High-grade Squamous Intraepithelial Lesions of the Uterine Cervix and p16, C-myc and PIK3CA Proteins-A Single-center Retrospective Study.", "datePublished": "2024-10-09", "url": "https://questionsmedicales.fr/article/39384698", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12013-024-01548-7" } }, { "@type": "ScholarlyArticle", "name": "Stratified Mucin-Producing Intraepithelial Lesion of the Cervix in an HPV- 16 Positive Woman: A Rare Encounter.", "datePublished": "2024-01-29", "url": "https://questionsmedicales.fr/article/38288809", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2174/0118715265284722240110114107" } }, { "@type": "ScholarlyArticle", "name": "Underdiagnosis of cervical intraepithelial neoplasia by colposcopy and its association with thin high‑grade squamous intraepithelial lesions.", "datePublished": "2023-05-19", "url": "https://questionsmedicales.fr/article/37274470", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3892/ol.2023.13873" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Résultats morphologiques et microscopiques", "item": "https://questionsmedicales.fr/mesh/D065308" }, { "@type": "ListItem", "position": 4, "name": "Lésions malpighiennes intra-épithéliales", "item": "https://questionsmedicales.fr/mesh/D000081483" }, { "@type": "ListItem", "position": 5, "name": "Lésions malpighiennes intra-épithéliales du col utérin", "item": "https://questionsmedicales.fr/mesh/D065310" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lésions malpighiennes intra-épithéliales du col utérin - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lésions malpighiennes intra-épithéliales du col utérin", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lésions malpighiennes intra-épithéliales du col utérin", "description": "Comment diagnostique-t-on ces lésions ?\nQuels tests sont utilisés pour le dépistage ?\nQuels sont les résultats possibles d'un frottis ?\nQuand faut-il répéter le frottis ?\nQuel rôle joue la biopsie dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lésions malpighiennes intra-épithéliales du col utérin", "description": "Quels symptômes peuvent indiquer des lésions ?\nLes douleurs pelviennes sont-elles un symptôme ?\nPeut-on avoir des symptômes urinaires ?\nLes pertes vaginales sont-elles un signe ?\nLes lésions provoquent-elles des démangeaisons ?", "url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lésions malpighiennes intra-épithéliales du col utérin", "description": "Comment prévenir les lésions malpighiennes ?\nQuel est le rôle du vaccin HPV ?\nÀ quel âge commencer le dépistage ?\nLes rapports protégés aident-ils à prévenir ?\nFaut-il éviter certains comportements ?", "url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lésions malpighiennes intra-épithéliales du col utérin", "description": "Quels traitements sont disponibles pour les lésions ?\nQuand faut-il envisager une conisation ?\nLa cryothérapie est-elle efficace ?\nQuels sont les effets secondaires des traitements ?\nFaut-il un suivi après traitement ?", "url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lésions malpighiennes intra-épithéliales du col utérin", "description": "Quelles sont les complications possibles ?\nLes lésions peuvent-elles récidiver ?\nY a-t-il des risques lors de la grossesse ?\nLes traitements affectent-ils la fertilité ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lésions malpighiennes intra-épithéliales du col utérin", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe nombre de partenaires sexuels influence-t-il le risque ?\nLe système immunitaire affecte-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on ces lésions ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par un frottis cervical et une colposcopie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le dépistage ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Le test Pap et le test HPV sont couramment utilisés pour le dépistage." } }, { "@type": "Question", "name": "Quels sont les résultats possibles d'un frottis ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les résultats peuvent être normaux, ASCUS, LSIL, HSIL ou cancer." } }, { "@type": "Question", "name": "Quand faut-il répéter le frottis ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il est recommandé de répéter le frottis tous les 3 ans après 21 ans." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie permet de confirmer la présence et le type de lésions." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer des lésions ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Souvent, il n'y a pas de symptômes, mais des saignements anormaux peuvent survenir." } }, { "@type": "Question", "name": "Les douleurs pelviennes sont-elles un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les douleurs pelviennes ne sont pas typiques des lésions malpighiennes." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes urinaires ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes urinaires ne sont généralement pas associés à ces lésions." } }, { "@type": "Question", "name": "Les pertes vaginales sont-elles un signe ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des pertes vaginales inhabituelles peuvent survenir, mais ce n'est pas spécifique." } }, { "@type": "Question", "name": "Les lésions provoquent-elles des démangeaisons ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les démangeaisons ne sont pas un symptôme courant des lésions malpighiennes." } }, { "@type": "Question", "name": "Comment prévenir les lésions malpighiennes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par le dépistage régulier et la vaccination contre le HPV." } }, { "@type": "Question", "name": "Quel est le rôle du vaccin HPV ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le vaccin HPV réduit le risque de développer des lésions précoces et le cancer." } }, { "@type": "Question", "name": "À quel âge commencer le dépistage ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage doit commencer à 21 ans, indépendamment de l'activité sexuelle." } }, { "@type": "Question", "name": "Les rapports protégés aident-ils à prévenir ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les rapports protégés réduisent le risque de transmission du HPV." } }, { "@type": "Question", "name": "Faut-il éviter certains comportements ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et avoir plusieurs partenaires sexuels peut réduire les risques." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les lésions ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la surveillance, la cryothérapie ou la conisation." } }, { "@type": "Question", "name": "Quand faut-il envisager une conisation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La conisation est envisagée pour les lésions HSIL ou si le suivi est difficile." } }, { "@type": "Question", "name": "La cryothérapie est-elle efficace ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la cryothérapie est efficace pour détruire les cellules anormales." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des saignements et des douleurs légères." } }, { "@type": "Question", "name": "Faut-il un suivi après traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier est essentiel pour surveiller les récidives." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le développement d'un cancer du col de l'utérus." } }, { "@type": "Question", "name": "Les lésions peuvent-elles récidiver ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les lésions peuvent récidiver, surtout si elles ne sont pas traitées." } }, { "@type": "Question", "name": "Y a-t-il des risques lors de la grossesse ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les lésions peuvent nécessiter un suivi accru pendant la grossesse." } }, { "@type": "Question", "name": "Les traitements affectent-ils la fertilité ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements, comme la conisation, peuvent affecter la fertilité." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical régulier et des traitements appropriés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent l'infection par le HPV et le tabagisme." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout après 30 ans." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer du col augmentent le risque." } }, { "@type": "Question", "name": "Le nombre de partenaires sexuels influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir de nombreux partenaires sexuels augmente le risque d'infection par le HPV." } }, { "@type": "Question", "name": "Le système immunitaire affecte-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un système immunitaire affaibli augmente le risque de développer des lésions." } } ] } ] }

Sources (10000 au total)

Stratified Mucin-Producing Intraepithelial Lesion of the Cervix in an HPV- 16 Positive Woman: A Rare Encounter.

Cervical cancer is the fourth most common cancer among women globally and has a strong association with Human Papillomavirus (HPV) infection. Stratified mucinproducing intraepithelial lesion (SMILE), ... The present case report briefs the finding of a 39-year-old woman who presented to the gynecological outpatient department with complaints of vaginal discharge for 6-8 months. She had no history of ir... The SMILE variant of AIS is a rare cervical precancerous lesion characterized by the morphological overlap of both squamous intraepithelial lesions and AIS. It is often difficult to diagnose on Pap sm... SMILE is a rare variant of AIS, which is often missed on cytological screening of the cervix. It is commonly associated with high-risk types of HPV. Hence, incorporating HPV testing in the screening o...

HiPorfin photodynamic therapy for vaginal high-grade squamous intraepithelial lesion.

We aimed to evaluate the efficacy and safety of HiPorfin-photodynamic therapy (PDT) in women with vaginal high-grade squamous intraepithelial Lesion (HSIL).... Retrospective analysis of eighteen patients with vaginal HSIL received HiPorfin-PDT between June 2019 and May 2023. Illumination with a 630-nm laser light was applied to the lesions 48-72 h after intr... The mean age of the 18 patients was 45.8 years (range, 24 to 63). The complete response (CR) rate was 66.7% (12/18), 83.3% (15/18) and 83.3% (15/18) at 3, 6 and 12 months after PDT, respectively. Pati... HiPorfin-PDT may be an effective alternative treatment for vaginal HSIL for organ-saving and sexual function protection....

Photodynamic therapy with HiPorfin for cervical squamous intraepithelial lesion at childbearing age.

To evaluate the clinical efficacy and safety of HiPorfin® photodynamic therapy (PDT) in the treatment of young women at reproductive age with high-grade squamous intraepithelial lesion (HSIL) of the c... Prospective study of 41 patients aged 28.8±4.6 years old with cervical intraepithelial neoplasia (CIN) Ⅱ-Ⅲ at Peking University Shenzhen Hospital from March 2019 to January 2023. HiPorfin® (2mg/kg) wa... All 41 patients with no recurrence had been observed at least 12 months follow-up period after PDT. The number of nulliparous women was 30 (30/41, 73.2%). CIN Ⅱ were 22 cases (22/41,53.7%) and CIN Ⅲ w... HiPorfin-PDT is a promising and organ-saving approach for cervical HSIL, which also eradicates HPV infection effectively and can be a beacon of hope for the young women with fertility preservation req...

To cut or not to cut - that is the question: a comparative analysis of long-term follow-up after complete and incomplete electroconization of the cervix due to high-grade squamous intraepithelial lesion.

Electroconization of the uterine cervix (LEEP/LLETZ) is an appropriate and sufficient procedure for high-grade squamous epithelial lesion - HSIL. Negative margins are considered fundamental for confir... The study has comprised 781 patients aged 18-85 - the research group was composed of 140 (17.93%) patients after incomplete conization and the control group of 641 (82.17%) patients after the complete... The statistical analysis results don't indicate a statistical significance between the frequency of HSIL in groups. HPV infection has increased the risk of persistent/recurrent lesions by 38 times, co... Close follow-up instead of inconsiderate repeat procedures should be taken under consideration among patients of reproductive age after incomplete conization of the cervix. HPV typing may be an essent...